BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

MLA

Tanino, Hirokazu, et al. “BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.” PloS One, vol. 11, no. 12, Dec. 2016, p. e0165721. EBSCOhost, https://doi.org/10.1371/journal.pone.0165721.

APA

Tanino, H., Kosaka, Y., Nishimiya, H., Tanaka, Y., Minatani, N., Kikuchi, M., Shida, A., Waraya, M., Katoh, H., Enomoto, T., Sengoku, N., Kajita, S., Hoffman, R. M., & Watanabe, M. (2016). BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. PloS One, 11(12), e0165721. https://doi.org/10.1371/journal.pone.0165721

Chicago

Tanino, Hirokazu, Yoshimasa Kosaka, Hiroshi Nishimiya, Youko Tanaka, Naoko Minatani, Mariko Kikuchi, Akiko Shida, et al. 2016. “BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.” PloS One 11 (12): e0165721. doi:10.1371/journal.pone.0165721.